Anesthesia awareness
This article was originally published in The Gray Sheet
Executive Summary
Bispectral index (BIS)-guided anesthesia with Aspect Medical's BIS Quatro Sensor does not lower the incidence of anesthesia awareness or reduce administration of volatile anesthetic gases compared with end-tidal anesthetic gas (ETAG) anesthesia, according to results of a 2,000-patient randomized study at Washington University, St. Louis, published in the March 13 New England Journal of Medicine. The results appear to contradict those of the 2,503-patient Australian B-Aware study, in which BIS reduced awareness by 82% compared to "standard clinical practice" (1"The Gray Sheet" Nov. 3, 2003, p. 26). "Reliance on BIS technology may provide practitioners with a false sense of security about the reduction in the risk of anesthesia awareness," authors Michael Avidan, et al., warn. Scott Kelley, M.D., Aspect Medical's medical director, maintains that the Washington University study did not show the same benefits of BIS as the earlier B-Aware trial because it used ETAG, instead of standard therapy, as the control. "The ETAG-guided protocol used in the NEJM study instructed the anesthesia professionals to use a certain amount of inhaled anesthetics and audible alarms set at the minimum level. This is not how anesthesia professionals routinely practice," said Kelley. "We would expect that a protocol which provides significant amounts of volatile anesthesia would produce a low incidence of awareness in these patients.
You may also be interested in...
Aspect Medical Defends BIS In Wake Of NEJM Study On Anesthesia Awareness
Aspect Medical Systems is defending the quality of clinical evidence supporting its Bispectral Index brain monitoring technology for reducing the risk of anesthesia awareness after a study published in the March 13 New England Journal of Medicine suggested no benefit from its use
Aspect BIS “Awareness” Indication Supported By Three Studies
An expanded indication for Aspect Medical's BIS bispectral index anesthesia monitoring technology for "reducing the risk of intraoperative awareness with recall" will be a competitive advantage, although the impact on sales remains undetermined, the firm says
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.